| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | Director, Director by Deputization, 10%+ Owner | Class B Common Stock, par value $0.0001 per share | 4,695,000 | $46,950,000 | $10.00 | 05 Aug 2021 | Through DA32 Sponsor LLC |
| DA32 Life Science Tech Acquisition Corp. | Director, Director by Deputization, 10%+ Owner | Class B Common Stock, par value $0.0001 per share | 4,665,000 | $46,650,000 | $10.00 | 05 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924321032284-section-32-fund-3-lp-2021-08-05 | DA32 Life Science Tech Acquisition Corp. | 05 Aug 2021 | 2 | $0 | 4 | Director, Director by Deputization, 10%+ Owner | 09 Aug 2021, 21:54 |
| /report/000089924321031450-section-32-fund-3-lp-2021-07-30 | DA32 Life Science Tech Acquisition Corp. | 30 Jul 2021 | 2 | +$14,500,000 | 4 | Director, Director by Deputization, 10%+ Owner | 03 Aug 2021, 21:47 |
| /report/000089924321030233-section-32-fund-3-lp-2021-07-27 | DA32 Life Science Tech Acquisition Corp. | 27 Jul 2021 | 0 | $0 | 3 | Director by Deputization, 10%+ Owner | 27 Jul 2021, 21:57 |